Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

Eli Lilly (LLY) and Novo Nordisk (NVO) are slashing prices of their GLP-1 products in China as the rivalry in the booming obesity drug market there intensifies amid local competition, according to ...

Novo Nordisk's long-term strategy for weight-loss treatments has earned praise from scientists, even as investors grow ...